» Articles » PMID: 7553863

Degradation of CFTR by the Ubiquitin-proteasome Pathway

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 1995 Oct 6
PMID 7553863
Citations 468
Authors
Affiliations
Soon will be listed here.
Abstract

Most cases of cystic fibrosis are caused by mutations that interfere with the biosynthetic folding of the cystic fibrosis transmembrane conductance regulator (CFTR), leading to the rapid degradation of CFTR molecules that have not matured beyond the endoplasmic reticulum (ER). The mechanism by which integral membrane proteins including CFTR are recognized and targeted for ER degradation and the proteolytic machinery involved in this process are not well understood. We show here that the degradation of both wild-type and mutant CFTR is inhibited by two potent proteasome inhibitors that induce the accumulation of polyubiquitinated forms of immature CFTR. CFTR degradation was also inhibited by coexpression of a dominant negative ubiquitin mutant and in cells bearing a temperature-sensitive mutation in the ubiquitin-activating enzyme, confirming that ubiquitination is required for rapid CFTR degradation.

Citing Articles

Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients.

Yin X, Shen H, Wang H, Wang Q, Zhang S, Zhang C Nat Commun. 2025; 16(1):2214.

PMID: 40044664 PMC: 11882848. DOI: 10.1038/s41467-025-57520-3.


Integrative Omics reveals changes in the cellular landscape of peroxisome-deficient yeast cells.

Kosir T, Das H, Pedersen M, Richard A, Anteghini M, Martins Dos Santos V Microb Cell. 2025; 12:9-33.

PMID: 40012703 PMC: 11862644. DOI: 10.15698/mic2025.02.842.


Evolutionary conserved regulation of TFEB stability by the E3 ubiquitin ligase WWP2 modulates response to stress .

Garcia-Sanchez J, Bonnet E, Loubatier C, Doye A, Paillier G, Segui F iScience. 2025; 28(2):111838.

PMID: 39995862 PMC: 11848471. DOI: 10.1016/j.isci.2025.111838.


Target Identification with Live-Cell Photoaffinity Labeling and Mechanism of Action Elucidation of ARN23765, a Highly Potent CFTR Corrector.

Romeo E, Saccoliti F, Ocello R, Andonaia A, Allegretta C, Pastorino C J Med Chem. 2025; 68(4):4596-4618.

PMID: 39928576 PMC: 11873939. DOI: 10.1021/acs.jmedchem.4c02654.


Functional rescue of F508del-CFTR through revertant mutations introduced by CRISPR base editing.

Carrozzo I, Maule G, Gentile C, Umbach A, Ciciani M, Guidone D Mol Ther. 2025; 33(3):970-985.

PMID: 39797401 PMC: 11897810. DOI: 10.1016/j.ymthe.2025.01.011.